Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes
Abstract Background Patients with systemic lupus erythematosus (SLE) suffered from an increasing risk of cardiovascular diseases. In this multi-center prospective study, we aimed to determine the association between antiphospholipid antibodies (aPLs) and future atherosclerotic cardiovascular disease...
Saved in:
Main Authors: | Can Huang, Yufang Ding, Zhen Chen, Lijun Wu, Wei Wei, Cheng Zhao, Min Yang, Shudian Lin, Qian Wang, Xinping Tian, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-024-03843-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective
by: Onder Onen, et al.
Published: (2020-12-01) -
A 10-Year Risk Assessment and Primary Prevention Study of Atherosclerotic Cardiovascular Disease Among Adult Patients in Saudi Arabia: A Cross-Sectional Study
by: Abdulhameed Alkhalaf, et al.
Published: (2025-01-01) -
A Case Report of Acupuncture Treatment on Antiphospholipid Syndrome Complicated by Cerebral Infarction
by: Chaoji XU, et al.
Published: (2017-08-01) -
Antiphospholipid Syndrome as a Cause of Recurrent Portal Vein Thrombosis in a Man with a Medical History of other Thrombosis
by: R. G. Sayfutdinov, et al.
Published: (2023-05-01) -
Bullous Pyoderma Gangrenosum Associated with Antiphospholipid Syndrome: A Case Report and Literature Review
by: Yousuf Alwashahi, et al.
Published: (2024-07-01)